SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,647,166 | -7.4% | 2,987,772 | +64.2% | 0.00% | – |
| Q3 2022 | $2,858,000 | +2.4% | 1,819,959 | +31.0% | 0.00% | – |
| Q2 2022 | $2,791,000 | -7.4% | 1,388,992 | +7.4% | 0.00% | – |
| Q1 2022 | $3,014,000 | +193.5% | 1,293,836 | +485.6% | 0.00% | – |
| Q4 2021 | $1,027,000 | -51.5% | 220,950 | -20.5% | 0.00% | – |
| Q3 2021 | $2,119,000 | -20.0% | 277,813 | +1.6% | 0.00% | – |
| Q2 2021 | $2,650,000 | -23.9% | 273,362 | -35.1% | 0.00% | – |
| Q1 2021 | $3,483,000 | +75.8% | 421,182 | +45.1% | 0.00% | – |
| Q4 2020 | $1,981,000 | -42.7% | 290,260 | -6.4% | 0.00% | – |
| Q3 2020 | $3,457,000 | +46.8% | 310,036 | -17.3% | 0.00% | – |
| Q2 2020 | $2,355,000 | +513.3% | 374,975 | +79.9% | 0.00% | – |
| Q1 2020 | $384,000 | -38.1% | 208,401 | +13.5% | 0.00% | – |
| Q4 2019 | $620,000 | +30.3% | 183,549 | -17.4% | 0.00% | – |
| Q3 2019 | $476,000 | -19.3% | 222,141 | +0.6% | 0.00% | – |
| Q2 2019 | $590,000 | -36.6% | 220,844 | +12.7% | 0.00% | – |
| Q1 2019 | $931,000 | +136.9% | 195,890 | +19.6% | 0.00% | – |
| Q4 2018 | $393,000 | -45.6% | 163,843 | -0.3% | 0.00% | – |
| Q3 2018 | $723,000 | -77.3% | 164,275 | -62.9% | 0.00% | -100.0% |
| Q2 2018 | $3,187,000 | +279.9% | 442,632 | +171.6% | 0.00% | – |
| Q1 2018 | $839,000 | +51.7% | 162,955 | +12.1% | 0.00% | – |
| Q4 2017 | $553,000 | +124.8% | 145,424 | +0.7% | 0.00% | – |
| Q3 2017 | $246,000 | -19.6% | 144,424 | -5.4% | 0.00% | – |
| Q2 2017 | $306,000 | -49.1% | 152,738 | +0.4% | 0.00% | – |
| Q1 2017 | $601,000 | -17.8% | 152,179 | +2.0% | 0.00% | – |
| Q4 2016 | $731,000 | +7210.0% | 149,122 | +11362.1% | 0.00% | – |
| Q3 2016 | $10,000 | +233.3% | 1,301 | +116.1% | 0.00% | – |
| Q2 2016 | $3,000 | -50.0% | 602 | -12.2% | 0.00% | – |
| Q4 2015 | $6,000 | -99.8% | 686 | -99.8% | 0.00% | -100.0% |
| Q3 2015 | $3,178,000 | +1861.7% | 378,861 | +4028.4% | 0.00% | – |
| Q2 2015 | $162,000 | -9.5% | 9,177 | -40.8% | 0.00% | – |
| Q1 2015 | $179,000 | +110.6% | 15,491 | +84.4% | 0.00% | – |
| Q4 2014 | $85,000 | +39.3% | 8,400 | -37.3% | 0.00% | – |
| Q3 2014 | $61,000 | -76.6% | 13,400 | -65.4% | 0.00% | – |
| Q2 2014 | $261,000 | -41.9% | 38,733 | +10.7% | 0.00% | – |
| Q1 2014 | $449,000 | -3.0% | 35,000 | -38.7% | 0.00% | – |
| Q4 2013 | $463,000 | – | 57,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |